Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Avai Bio (AVAI) EBIT Margin (2019 - 2020)

Avai Bio's EBIT Margin history spans 2 years, with the latest figure at 269.52% for Q4 2020.

  • On a quarterly basis, EBIT Margin changed N/A to 269.52% in Q4 2020 year-over-year; TTM through Dec 2020 was 5.52%, a 137032.0% increase, with the full-year FY2023 number at 306.86%, changed N/A from a year prior.
  • EBIT Margin hit 269.52% in Q4 2020 for Avai Bio, up from 14.23% in the prior quarter.
  • Over the last five years, EBIT Margin for AVAI hit a ceiling of 269.52% in Q4 2020 and a floor of 244.93% in Q2 2019.